Inventiva (IVA) Free Cash Flow (2019 - 2025)
Inventiva's (IVA) quarterly Free Cash Flow came in at $121.7 million in Q2 2025, up 335.0% year-on-year from $28.0 million in Q2 2024, and up 335.0% quarter-over-quarter from -$51.8 million in Q2 2024.
Inventiva (IVA) Free Cash Flow (2019 - 2025) Analysis & Trends
Inventiva's Free Cash Flow history runs 6 years deep, the most recent figure standing at $121.7 million for Q2 2025.
- On a quarterly basis, Free Cash Flow rose 335.0% year-over-year to $121.7 million in Q2 2025; TTM through Dec 2025 was $69.9 million, a 235.0% increase from a year earlier, with the FY2025 full-year figure at -$122.1 million, down 32.96% from the prior year.
- Free Cash Flow grew to $121.7 million in Q2 2025 per IVA's latest filing, from -$51.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $121.7 million in Q2 2025 and bottomed at -$51.8 million in Q2 2024.
- The 4-year median for Free Cash Flow is -$22.5 million (2021), against an average of -$4.2 million.
- Across the five-year window, Free Cash Flow slumped 262.03% in 2021 and soared 335.0% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$22.5 million in 2021, then retreated by 17.76% to -$26.4 million in 2022, then plunged by 95.78% to -$51.8 million in 2024, then surged by 335.0% to $121.7 million in 2025.
- Per Business Quant, the three latest IVA Free Cash Flow figures stand at $121.7 million (Q2 2025), -$51.8 million (Q2 2024), and -$26.4 million (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 121.69 Mn |
| Jun 30, 2025 | 121.69 Mn |
| Jun 30, 2024 | -51.78 Mn |
| Jun 30, 2024 | -51.78 Mn |
| Dec 31, 2022 | -26.45 Mn |
| Dec 31, 2022 | -26.45 Mn |
| Sep 22, 2022 | -27.05 Mn |
| Sep 22, 2022 | -27.05 Mn |
| Dec 31, 2021 | -22.46 Mn |
| Dec 31, 2021 | -22.46 Mn |
| Jun 30, 2021 | -14.32 Mn |
| Jun 30, 2021 | -14.32 Mn |
| Mar 31, 2021 | -9.34 Mn |
| Mar 31, 2021 | -9.34 Mn |
| Dec 31, 2020 | -8.55 Mn |
| Dec 31, 2020 | -8.55 Mn |
| Jun 30, 2020 | -3.96 Mn |
| Jun 30, 2020 | -3.96 Mn |
| Mar 31, 2020 | -3.95 Mn |
| Mar 31, 2020 | -3.95 Mn |